Sunitinib for the First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma
Technology Appraisal Guidance No. 169 Source: National Institute for Health and Clinical...
Jump to:
Click on a title in the list below to view the relevant table.
1. Guidance 1.1 Rivaroxaban, within its marketing authorisation, is recommended as an...
Technology Appraisal Guidance No. 169 Source: National Institute for Health and Clinical...
Technology Appraisal Guidance No. 168 Source: National Institute for Health and Clinical...
Technology Appraisal Guidance No. 162 Source: National Institute for Health and Clinical...
Technology Appraisal Guidance No. 163 Source: National Institute for Health and Clinical...
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
Cumulative list of products discontinued from the UK market
in 2009.